XML 45 R9.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Other Income | 12 Months Ended
--- | ---
Sep. 30, 2019
Component of Operating Income [Abstract] |
Other Income |
Note 3 | Other Income
Grant income During the year ended September 30, 2017, the Company was awarded grant funding in the amount of $597,886. The grant is being received in equal quarterly installments over a period of two years beginning during the year ended September 30, 2018, in exchange for a commitment to complete clinical testing for a therapeutic drug candidate for the treatment of Rett syndrome. The grant income is deferred when received and amortized to other income as the related research and development expenditures are incurred. During the year ended September 30, 2019, the Company recognized $298,943 (2018: $149,055) of this grant on its statement of operations as a component of other income. Research and development incentive income Research and development incentive income represents the receipt by the Company’s Australian subsidiary, of the Australian research and development incentive credit, (the “ATO R&D Credit”), as well as receipt by the Company of the New York City Biotechnology Tax Credit (“NYC Biotech credit”). During the year ended September 30, 2019, the Company recorded research and development incentive income of $2,215,691 (AUD 3,281,300) (2018: $1,647,219 (AUD 2,344,486)) in respect of the ATO R&D Credit for eligible research and development expenses incurred during the year. During the year ended September 30, 2019, the Company recorded research and development incentive income of $250,000 (2018: $182,967) in respect of the NYC Biotech Credit awarded to the Company during the year.

X
- Definition Disclosure of other income disclosure. + References No definition available. + Details
Name: | avxl_OtherIncomeDisclosureTextBlock
Namespace Prefix: | avxl_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_OtherIncomeAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration